Back to search

Article

Temozolomide-induced glioma cytotoxicity is enhanced by inhibition of Sirt7, which is involved in growth and progression and is regulated by miR-148a-3p

2024-02-29

Abstract excerpt

<h4>Background: </h4> Glioma is a highly malignant primary nervous system tumor. Temozolomide(TMZ) is a commonly used chemotherapy drug, but drug resistance is increasing. Therefore, finding effective biomarkers can help us to better stratify and individualize treatment. Sirt7 is the latest member of sirtuins, which mainly plays the role of NAD+-dependent histone deacetylase. In recent years, Sirt7 has been report...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a919019a-0102-5206-9bc9-7c58062bf9bd
DOI
10.21203/rs.3.rs-3977967/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Temozolomide-induced glioma cytotoxicity is enhanced by inhibition of Sirt7, which is involved in growth and progression and is regulated by miR-148a-3pDOI 10.21203/rs.3.rs-3977967/v1
Select a neighboring publication to make it the new centre.